Search Results - "Sailer, Scott"

Randomized Controlled Trial of Interval-Compressed Chemotherapy for the Treatment of Localized Ewing Sarcoma: A Report From the Children's Oncology Group by WOMER, Richard B, WEST, Daniel C, WEISS, Aaron R, KRAILO, Mark D, DICKMAN, Paul S, PAWEL, Bruce R, GRIER, Holcombe E, MARCUS, Karen, SAILER, Scott, HEALEY, John H, DORMANS, John P

“…Chemotherapy with alternating vincristine-doxorubicin-cyclophosphamide and ifosfamide-etoposide cycles and primary tumor treatment with surgery and/or…”
Get full text

Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: A report from the Children's Oncology Group by DuBois, Steven G., Krailo, Mark D., Gebhardt, Mark C., Donaldson, Sarah S., Marcus, Karen J., Dormans, John, Shamberger, Robert C., Sailer, Scott, Nicholas, Richard W., Healey, John H., Tarbell, Nancy J., Randall, R. Lor, Devidas, Meenakshi, Meyer, James S., Granowetter, Linda, Womer, Richard B., Bernstein, Mark, Marina, Neyssa, Grier, Holcombe E.

“…BACKGROUND Patients with Ewing sarcoma require local primary tumor control with surgery, radiation, or both. The optimal choice of local control for overall…”
Get full text

Dose-Intensified Compared With Standard Chemotherapy for Nonmetastatic Ewing Sarcoma Family of Tumors: A Children's Oncology Group Study by GRANOWETTER, Linda, WOMER, Richard, COOPER SHAMBERGER, Robert, GOORIN, Allen, MISER, James, MEYER, James, ARNDT, Carola A. S, SAILER, Scott, MARCUS, Karen, PERLMAN, Elizabeth, DICKMAN, Paul, GRIER, Holcombe E, DEVIDAS, Meenakshi, KRAILO, Mark, CHENGUANG WANG, BERNSTEIN, Mark, MARINA, Neyssa, LEAVEY, Patrick, GEBHARDT, Mark, HEALEY, John

“…The Ewing sarcoma family of tumors (ESFT) is a group of malignant tumors of soft tissue and bone sharing a chromosomal translocation affecting the EWS locus…”
Get full text

A pilot study of low-dose anti-angiogenic chemotherapy in combination with standard multiagent chemotherapy for patients with newly diagnosed metastatic Ewing sarcoma family of tumors: A Children's Oncology Group (COG) Phase II study NCT00061893 by Felgenhauer, Judy L., Nieder, Michael L., Krailo, Mark D., Bernstein, Mark L., Henry, David W., Malkin, David, Baruchel, Sylvain, Chuba, Paul J., Sailer, Scott L., Brown, Ken, Ranganathan, Sarangarajan, Marina, Neyssa

“…Background The aims of this study were to determine the feasibility of the combination of low dose, anti‐angiogenic chemotherapy with standard therapy for…”
Get full text

An evaluation of the variability of tumor-shape definition derived by experienced observers from CT images of supraglottic carcinomas (ACRIN protocol 6658) by Cooper, Jay S., M.D, Mukherji, Suresh K., M.D, Toledano, Alicia Y., Sc.D, Beldon, Clifford, M.D, Schmalfuss, Ilona M., M.D, Amdur, Robert, M.D, Sailer, Scott, M.D, Loevner, Laurie A., M.D, Kousouboris, Phil, M.D, Ang, K. Kian, M.D., Ph.D, Cormack, Jean, Ph.D, Sicks, JoRean, M.S

“…Purpose: Accurate target definition is considered essential for sophisticated, image-guided radiation therapy; however, relatively little information has been…”
Get full text

High-Dose Melphalan, Etoposide, Total-Body Irradiation, and Autologous Stem-Cell Reconstitution as Consolidation Therapy for High-Risk Ewing’s Sarcoma Does Not Improve Prognosis by MEYERS, Paul A, KRAILO, Mark D, HERZOG, Cynthia E, LINDSLEY, Karen L, LIU-MARES, Wen, NACHMAN, James B, SIEGER, Lance, WADMAN, Jean, GORLICK, Richard G, LADANYI, Marc, CHAN, Ka-Wah, SAILER, Scott L, DICKMAN, Paul S, BAKER, David L, DAVIS, Jeffrey H, GERBING, Robert B, GROVAS, Alfred

“…To determine whether consolidation therapy with high-dose melphalan, etoposide, and total-body irradiation (TBI) with autologous stem-cell support would…”
Get full text

Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406 by Michalski, J M, Purdy, J A, Winter, K, Roach, 3rd, M, Vijayakumar, S, Sandler, H M, Markoe, A M, Ritter, M A, Russell, K J, Sailer, S, Harms, W B, Perez, C A, Wilder, R B, Hanks, G E, Cox, J D

“…A prospective Phase I dose escalation study was conducted to determine the maximally-tolerated radiation dose in men treated with three-dimensional conformal…”
Get more information

Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy by Shamberger, Robert C, LaQuaglia, Michael P, Gebhardt, Mark C, Neff, James R, Tarbell, Nancy J, Marcus, Karen C, Sailer, Scott L, Womer, Richard B, Miser, James S, Dickman, Paul S, Perlman, Elizabeth J, Devidas, Meenakshi, Linda, Stephen B, Krailo, Mark D, Grier, Holcombe E, Granowetter, Linda

“…To establish outcome and optimal timing of local control for patients with nonmetastatic Ewing sarcoma/primitive neuroectodermal tumor (ES/PNET) of the chest…”
Get full text

Radiation therapy for prostate cancer: external beam, brachytherapy, and salvage by Sailer, Scott L

“…Radiation is a curative treatment for prostate cancer that is most appropriate for the older patient or the patient with significant co-morbidities. Younger…”
Get full text

Intensification of Therapy for Children With Lower-Risk Acute Lymphoblastic Leukemia: Long-Term Follow-Up of Patients Treated on Children’s Cancer Group Trial 1881 by HUTCHINSON, Raymond J, GAYNON, Paul S, SATHER, Harland, BERTOLONE, Salvatore J, COOPER, Herbert A, TANNOUS, Raymond, WELLS, Linda M, HEEREMA, Nyla A, SAILER, Scott, TRIGG, Michael E

“…From December 1988 through December 1992, the Children's Cancer Group (CCG) conducted a randomized trial (CCG-1881) designed to evaluate the impact of adding a…”
Get full text

Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience by Kennedy, Andrew S, Coldwell, Douglas, Nutting, Charles, Murthy, Ravi, Wertman, Jr, Daniel E, Loehr, Stephen P, Overton, Carroll, Meranze, Steven, Niedzwiecki, Jerry, Sailer, Scott

“…Salvage therapy for patients with unresectable colorectal liver metastases that were refractory to oxaliplatin and irinotecan was performed via radioactive…”
Get more information

Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group by Matloub, Yousif, Bostrom, Bruce C., Hunger, Stephen P., Stork, Linda C., Angiolillo, Anne, Sather, Harland, La, Mei, Gastier-Foster, Julie M., Heerema, Nyla A., Sailer, Scott, Buckley, Patrick J., Thomson, Blythe, Cole, Catherine, Nachman, James B., Reaman, Gregory, Winick, Naomi, Carroll, William L., Devidas, Meenakshi, Gaynon, Paul S.

“…Children's Cancer Group-1991 selected 2 components from the Children's Cancer Group studies shown to be effective in high-risk acute lymphoblastic leukemia and…”
Get full text

Risk Factors Associated with COVID-19 Hospitalization and Mortality: A Large Claims-Based Analysis Among People with Type 2 Diabetes Mellitus in the United States by Boye, Kristina S., Tokar Erdemir, Elif, Zimmerman, Nathan, Reddy, Abraham, Benneyworth, Brian D., Dabora, Matan C., Hankosky, Emily R., Bethel, M. Angelyn, Clark, Callahan, Lensing, Cody J., Sailer, Scott, San Juan, Ramira, Heine, Robert J., Etemad, Lida

“…Introduction Diabetes has been identified as a high-risk comorbidity for COVID-19 hospitalization. We evaluated additional risk factors for COVID-19…”
Get full text

90 Y radioembolization for neuroendocrine cancers liver metastases provides sustained therapeutic effect with minimal toxicity by Kennedy, Andrew S., Elkordy, Maha, Campbell, Elizabeth Estill, Albertson, Brent, Sailer, Scott Lee, Deutsch, Margaret Ann

“…Abstract only 343 Background: Radioembolization (RE) is the delivery of radioactive microspheres ( 90 Y) via the hepatic artery, which permanently implant…”
Get full text

Ovarian carcinoma in an adolescent with transgenerational exposure to diethylstilbestrol by BLATT, Julie, VAN LE, Linda, WEINER, Timothy, SAILER, Scott

“…Small cell carcinoma of the ovary is rare in adolescence. The etiology of such tumors is unknown. Several reports suggest that transgenerational exposure to…”
Get full text

Virtual simulation: initial clinical results by Rosenman, J, Sailer, S L, Sherouse, G W, Chaney, E L, Tepper, J E

“…We have developed a graphics-based three-dimensional treatment design system that permits the physician to easily understand which anatomy will be treated for…”
Get more information

Evaluation of local control strategies in patients with localized Ewing sarcoma of bone: A report from the Children’s Oncology Group by DuBois, Steven G., Krailo, Mark D., Gebhardt, Mark C., Donaldson, Sarah S., Marcus, Karen Chayt, Dormans, John P., Shamberger, Robert C., Sailer, Scott Lee, Nicholas, Richard W., Healey, John H., Tarbell, Nancy, Devidas, Meenakshi, Meyer, James S., Granowetter, Linda, Womer, Richard, Bernstein, Mark L., Marina, Neyssa, Grier, Holcombe E.

“…Abstract only 9537 Background: Patients (pts) with Ewing sarcoma (EWS) require local control, either with surgery alone (S), radiation alone (R), or a…”
Get full text

A Pilot Study of Low-Dose Anti-angiogenic Chemotherapy in Combination with Standard Multiagent Chemotherapy for Patients with Newly Diagnosed Metastatic Ewing Sarcoma Family of Tumors: A Children's Oncology Group (COG) Phase II Study by Felgenhauer, Judy L., Nieder, Michael L., Krailo, Mark D., Bernstein, Mark L., Henry, David W., Malkin, David, Baruchel, Sylvain, Chuba, Paul J., Sailer, Scott L., Brown, Ken, Ranganathan, Sarangarajan, Marina, Neyssa

Get full text

Chemoradiation for Locally Advanced Squamous Cell Carcinoma of the Head and Neck for Organ Preservation and Palliation by Poole, Michael E, Sailer, Scott L, Rosenman, Julian G, Tepper, Joel E, Weissler, Mark C, Shockley, William W, Yarbrough, Wendell G, Pillsbury III, Harold C, Schell, Michael J, Bernard, Stephen A

“…OBJECTIVES To measure the efficacy and toxic effects of our chemoradiotherapy regimen by means of response and survival in patients with advanced squamous cell…”
Get full text

Recent advances in radiotherapy treatment planning by Rosenman, J, Chaney, E L, Sailer, S, Sherouse, G W, Tepper, J E

“…Radiation treatment planning is currently in a state of rapid change. Dissatisfaction with past planning technology stems from the growing realization that:…”
Get more information